Developer docs
API playgroundTry for free, no card

Search company profiles

Europe PubMed Central

Full company profile

uuid0024xsj

Namestring
Europe PubMed Central
Legal namestring
Europe PMC
Websiteurl
europepmc.org
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Europe PubMed Central (Europe PMC) is a free, open-access repository of life sciences literature operated by the European Bioinformatics Institute (EMBL-EBI) on behalf of a consortium of 35 European and international biomedical research funders. Launched in 2007 as UKPMC and rebranded to Europe PMC in November 2012, the platform provides a single searchable entry point to over 48.3 million publication records including abstracts, full-text articles, preprints, books, and patents, with 1.7 million new articles added annually and 8.7 million full-text articles available.

The platform's technical stack centers on a Solr-based search engine (migrated in August 2016 for a 20x performance improvement), augmented by a text-mining pipeline that has produced over 1.3 billion entity annotations accessible via SciLite. Europe PMC exposes its content through RESTful APIs for articles and grants (GRIST), a SOAP web service, an Annotations API, an OAI service, and bulk JATS XML downloads. It is part of PubMed Central International alongside the US NLM's PMC, is designated an ELIXIR Core Data Resource and a Global Core Biodata Resource, and integrates with ORCID, ROR, Crossref, Unpaywall, and scite.ai. Europe PMC Plus is the manuscript submission and grant reporting system for authors funded by member organizations, originally developed in partnership with Coko, eLife, and Hindawi.

Europe PMC is not a commercial enterprise: there is no pricing model, no paying end-user customer, and no equity ownership. Operating revenue consists entirely of multi-year infrastructure grants from public and charitable research funders, with the most recent grant covering April 2021 to March 2026. The organization adopted the Principles of Open Scholarly Infrastructure (POSI) in February 2021. Distribution is entirely self-serve through the website, APIs, and bulk download channels.

Short descriptiontext

Europe PubMed Central (Europe PMC) is a free, open-access repository of over 48 million life sciences publications operated by EMBL-EBI and funded by 35 European and international biomedical research funders, serving academic researchers, funders, authors, and healthcare professionals globally.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
biomedical literature repository, open access publishing, life sciences search, scientific literature database, text-mining annotations
Industry1 code
1Medical & Clinical Reference (Physicians, Nursing, Allied Health)
CodeEDAGAGAAPrimaryYes
NAICS code1 code
  • Libraries and Archives51921
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Scientific Literature Repository
Social media profiles2 records
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Europe PubMed Central (Europe PMC) is a free, open-access repository providing access to over 48 million life sciences literature records including abstracts, full-text articles, preprints, books, and patents. The platform offers Solr-powered search, text-mined annotations via SciLite, manuscript submission through Europe PMC Plus, grant discovery via Grant Finder, and multiple APIs (RESTful, SOAP, Annotations, OAI) for programmatic access. It is developed and maintained by EMBL-EBI as part of the PubMed Central International archive network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Searches are on average 20 times quicker using Solr than previous search engine
+1 more record
Product overview1 text field

Europe PMC is a comprehensive open access repository of life science literature offering over 48 million records. The platform consists of the core Europe PMC Search Platform combined with Europe PMC Plus (manuscript submission and grant reporting), Grant Finder (biomedical grants search), and SciLite (annotation highlighting). It provides multiple API products including RESTful APIs for articles and grants, SOAP web service, Annotations API, and OAI service for interoperability. Additional tools include the Funders' Dashboard, Article Status Monitor, ORCID article claiming, External Links Service, and Europe PMC Bookshelf for monographs and reports.

Product and service3 records
1Europe PMC Search Platform
CategoryCore Search Platform
Description

The main searchable database providing access to over 48 million life sciences literature records including abstracts, full-text articles, preprints, books, and patents. Features Solr-powered intuitive search, advanced filtering, and linked resources for life sciences researchers globally.

2Europe PMC Plus
CategoryManuscript Submission System
Description

Manuscript submission system for authors funded by Europe PMC funders to deposit accepted manuscripts for open access availability in Europe PMC and PMC USA. Includes grant reporting functionality for funded authors.

3Grant Finder
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-05-01
Description

Community partner in the development of the open source manuscript submission system, contributing to the PubSweet framework.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-05-01
Description

Community partner in the open source manuscript submission system development using PubSweet technology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-05-01
Description

Partnership to develop the new Europe PMC Plus manuscript submission system using PubSweet technology framework for modern, digital-first manuscript processing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Europe PMC is developed and maintained by EMBL-EBI as part of the European Molecular Biology Laboratory. EMBL-EBI provides the technical infrastructure, development resources, and operational support for the platform.

5PubMed Central (PMC) / National Library of Medicine (NLM)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Part of the PubMed Central International (PMCI) archive network, collaborating with NCBI/NLM to preserve and provide free access to biomedical literature. Content is synchronized with PMC USA.

europepmc.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Designated as an ELIXIR Core Data Resource and Global Core Biodata Resource, supporting data preservation and open science infrastructure across Europe.

7Europe PMC Funders' Group
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Consortium of 35 European and international biomedical research funders who support and fund the Europe PMC infrastructure, including Wellcome Trust, MRC, ERC, and others.

europepmc.org
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Preprint servers whose content Europe PMC indexes for discovery; comparable in serving open access biomedical science and increasingly building their own discovery and analytics features that overlap with Europe PMC's value proposition.

TypeDirect peer
Description

AI-powered scholarly search engine covering biomedical literature with semantic understanding and citation context; a next-generation direct competitor in scientific literature discovery serving overlapping researcher segments.

TypeDirect peer
Description

A non-profit data citation infrastructure providing DOIs for research datasets; comparable as open scholarly infrastructure serving research data discoverability alongside Europe PMC's literature focus.

TypeEmerging player
Description

A research analytics platform that links publications, grants, and citations—overlapping with Europe PMC's Grant Finder and Funders' Dashboard products for tracking research outputs and impact.

TypeEmerging player
Description

An open-access publisher partnered with Europe PMC on the PubSweet manuscript submission framework; comparable as an open-science platform serving biomedical researchers with overlapping community and infrastructure ambitions.

TypeDirect peer
Description

A non-profit scholarly infrastructure organization providing DOIs and metadata services; Europe PMC integrates Crossref data and its funder-side grant ID work overlaps with Europe PMC's GRIST, making them sibling infrastructure providers.

TypeDirect peer
Description

Non-profit researcher identifier infrastructure deeply integrated with Europe PMC for author claiming and profile pages; serves the same research community as a complementary layer of scholarly infrastructure.

8PubMed Central (PMC)
TypeDirect peer
Description

The US counterpart to Europe PMC in the PubMed Central International network; both host full-text biomedical literature with synchronized content, share author manuscript workflows, and serve the same researcher base with free open access.

9PubMed
TypeDirect peer
Description

The NLM-maintained biomedical literature search engine indexing 35M+ citations; directly comparable in target audience (life sciences researchers) and core service (free literature search), with which Europe PMC synchronizes much of its content.

10Scopus
TypeBroad incumbent
Description

Elsevier's broad scholarly literature database; a much larger commercial incumbent serving similar literature search and citation tracking use cases across all disciplines rather than specializing in open biomedical access.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Europe PubMed Central

Scientific Literature Repositoryeuropepmc.org

Europe PubMed Central (Europe PMC) is a free, open-access repository of over 48 million life sciences publications operated by EMBL-EBI and funded by 35 European and international biomedical research funders, serving academic researchers, funders, authors, and healthcare professionals globally.

What Europe PubMed Central does

Europe PubMed Central (Europe PMC) is a free, open-access repository of life sciences literature operated by the European Bioinformatics Institute (EMBL-EBI) on behalf of a consortium of 35 European and international biomedical research funders. Launched in 2007 as UKPMC and rebranded to Europe PMC in November 2012, the platform provides a single searchable entry point to over 48.3 million publication records including abstracts, full-text articles, preprints, books, and patents, with 1.7 million new articles added annually and 8.7 million full-text articles available.

The platform's technical stack centers on a Solr-based search engine (migrated in August 2016 for a 20x performance improvement), augmented by a text-mining pipeline that has produced over 1.3 billion entity annotations accessible via SciLite. Europe PMC exposes its content through RESTful APIs for articles and grants (GRIST), a SOAP web service, an Annotations API, an OAI service, and bulk JATS XML downloads. It is part of PubMed Central International alongside the US NLM's PMC, is designated an ELIXIR Core Data Resource and a Global Core Biodata Resource, and integrates with ORCID, ROR, Crossref, Unpaywall, and scite.ai. Europe PMC Plus is the manuscript submission and grant reporting system for authors funded by member organizations, originally developed in partnership with Coko, eLife, and Hindawi.

Europe PMC is not a commercial enterprise: there is no pricing model, no paying end-user customer, and no equity ownership. Operating revenue consists entirely of multi-year infrastructure grants from public and charitable research funders, with the most recent grant covering April 2021 to March 2026. The organization adopted the Principles of Open Scholarly Infrastructure (POSI) in February 2021. Distribution is entirely self-serve through the website, APIs, and bulk download channels.

Europe PubMed Central firmographics

Firmographics
Name
Europe PubMed Central
Legal name
Europe PMC
Website
https://europepmc.org
Company type
Private
Founded year
2007
Operating status
Operating
Short description
Europe PubMed Central (Europe PMC) is a free, open-access repository of over 48 million life sciences publications operated by EMBL-EBI and funded by 35 European and international biomedical research funders, serving academic researchers, funders, authors, and healthcare professionals globally.
Ownership category
akta.pro rank

Europe PubMed Central industry classification

Industry
Product category
Scientific Literature Repository
NAICS
Libraries and Archives (51921)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

  • Biomedical literature repository
  • Open access publishing
  • Life sciences search
  • Scientific literature database
  • Text-mining annotations

Where Europe PubMed Central is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Europe PubMed Central business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Distribution channels4 records

Marketing channels8 records

Europe PubMed Central product offering

Product offering

Core offering

Europe PubMed Central (Europe PMC) is a free, open-access repository providing access to over 48 million life sciences literature records including abstracts, full-text articles, preprints, books, and patents. The platform offers Solr-powered search, text-mined annotations via SciLite, manuscript submission through Europe PMC Plus, grant discovery via Grant Finder, and multiple APIs (RESTful, SOAP, Annotations, OAI) for programmatic access. It is developed and maintained by EMBL-EBI as part of the PubMed Central International archive network.

Product overview

Europe PMC is a comprehensive open access repository of life science literature offering over 48 million records. The platform consists of the core Europe PMC Search Platform combined with Europe PMC Plus (manuscript submission and grant reporting), Grant Finder (biomedical grants search), and SciLite (annotation highlighting). It provides multiple API products including RESTful APIs for articles and grants, SOAP web service, Annotations API, and OAI service for interoperability. Additional tools include the Funders' Dashboard, Article Status Monitor, ORCID article claiming, External Links Service, and Europe PMC Bookshelf for monographs and reports.

Differentiator

Problem solved

Functional benefit

Products and services

  • Europe PMC Search Platform The main searchable database providing access to over 48 million life sciences literature records including abstracts, full-text articles, preprints, books, and patents. Features Solr-powered intuitive search, advanced filtering, and linked resources for life sciences researchers globally.
  • Europe PMC Plus Manuscript submission system for authors funded by Europe PMC funders to deposit accepted manuscripts for open access availability in Europe PMC and PMC USA. Includes grant reporting functionality for funded authors.
  • Grant Finder

Quantifiable outcome

  • Searches are on average 20 times quicker using Solr than previous search engine
  • +1 more outcomes

Companies that use Europe PubMed Central

Customer profile

Segments4 records

Ideal customer profiles3 records

Europe PubMed Central technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability7 records

Feature7 records

Europe PubMed Central partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • eLifeminorStrategic or Co-development Partner · 1 May 2019Community partner in the development of the open source manuscript submission system, contributing to the PubSweet framework.
  • HindawiminorStrategic or Co-development Partner · 1 May 2019Community partner in the open source manuscript submission system development using PubSweet technology.
  • Collaborative Knowledge Foundation (Coko)coreStrategic or Co-development Partner · 1 May 2018Partnership to develop the new Europe PMC Plus manuscript submission system using PubSweet technology framework for modern, digital-first manuscript processing.
  • EMBL-EBI (European Bioinformatics Institute)coreStrategic or Co-development PartnerEurope PMC is developed and maintained by EMBL-EBI as part of the European Molecular Biology Laboratory. EMBL-EBI provides the technical infrastructure, development resources, and operational support for the platform.
  • PubMed Central (PMC) / National Library of Medicine (NLM)coreStrategic or Co-development PartnerPart of the PubMed Central International (PMCI) archive network, collaborating with NCBI/NLM to preserve and provide free access to biomedical literature. Content is synchronized with PMC USA.
  • ELIXIRcoreStrategic or Co-development PartnerDesignated as an ELIXIR Core Data Resource and Global Core Biodata Resource, supporting data preservation and open science infrastructure across Europe.
  • Europe PMC Funders' GroupcoreStrategic or Co-development PartnerConsortium of 35 European and international biomedical research funders who support and fund the Europe PMC infrastructure, including Wellcome Trust, MRC, ERC, and others.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Europe PubMed Central competitors and assessment

Company assessment

Emerging players

  • bioRxiv / medRxiv: Preprint servers whose content Europe PMC indexes for discovery; comparable in serving open access biomedical science and increasingly building their own discovery and analytics features that overlap with Europe PMC's value proposition.
  • Dimensions: A research analytics platform that links publications, grants, and citations—overlapping with Europe PMC's Grant Finder and Funders' Dashboard products for tracking research outputs and impact.
  • eLife: An open-access publisher partnered with Europe PMC on the PubSweet manuscript submission framework; comparable as an open-science platform serving biomedical researchers with overlapping community and infrastructure ambitions.

Direct peers

  • Semantic Scholar: AI-powered scholarly search engine covering biomedical literature with semantic understanding and citation context; a next-generation direct competitor in scientific literature discovery serving overlapping researcher segments.
  • DataCite: A non-profit data citation infrastructure providing DOIs for research datasets; comparable as open scholarly infrastructure serving research data discoverability alongside Europe PMC's literature focus.
  • Crossref: A non-profit scholarly infrastructure organization providing DOIs and metadata services; Europe PMC integrates Crossref data and its funder-side grant ID work overlaps with Europe PMC's GRIST, making them sibling infrastructure providers.
  • ORCID: Non-profit researcher identifier infrastructure deeply integrated with Europe PMC for author claiming and profile pages; serves the same research community as a complementary layer of scholarly infrastructure.
  • PubMed Central (PMC): The US counterpart to Europe PMC in the PubMed Central International network; both host full-text biomedical literature with synchronized content, share author manuscript workflows, and serve the same researcher base with free open access.
  • PubMed: The NLM-maintained biomedical literature search engine indexing 35M+ citations; directly comparable in target audience (life sciences researchers) and core service (free literature search), with which Europe PMC synchronizes much of its content.

Broad incumbents

  • Scopus: Elsevier's broad scholarly literature database; a much larger commercial incumbent serving similar literature search and citation tracking use cases across all disciplines rather than specializing in open biomedical access.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

Europe PubMed Central social profiles

Digital presence

Europe PubMed Central compliance and trust

Trust signal

Compliance4 records

Europe PubMed Central financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Europe PubMed Central leadership team

Management profile

Number of profiles

Profiles2 records

Europe PubMed Central funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Europe PubMed Central M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Europe PubMed Central

What does Europe PubMed Central do?

Europe PubMed Central (Europe PMC) is a free, open-access repository providing access to over 48 million life sciences literature records including abstracts, full-text articles, preprints, books, and patents. The platform offers Solr-powered search, text-mined annotations via SciLite, manuscript submission through Europe PMC Plus, grant discovery via Grant Finder, and multiple APIs (RESTful, SOAP, Annotations, OAI) for programmatic access. It is developed and maintained by EMBL-EBI as part of the PubMed Central International archive network.

Is Europe PubMed Central a public or private company?

Europe PubMed Central is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Europe PubMed Central founded?

Europe PubMed Central was founded in 2007.

Where is Europe PubMed Central based?

Europe PubMed Central is headquartered in London, United Kingdom, in the Europe region.

Who are Europe PubMed Central's main competitors?

Emerging players on record are bioRxiv / medRxiv, Dimensions and eLife. Direct peers are Semantic Scholar, DataCite, Crossref, ORCID, PubMed Central (PMC) and PubMed. Scopus is listed as a broad incumbent.

Does Europe PubMed Central have an API?

Yes. Europe PMC offers multiple programmatic interfaces: Articles RESTful API for searching publications, Grants RESTful API (GRIST) for grant data, SOAP web service, Annotations API for text-mined annotations, and OAI service. APIs provide access to over 48 million life science literature records including abstracts, full-text articles, preprints, grants, and citations. The REST API supports various formats including XML, JSON, and PMID lists. Developer documentation is at europepmc.org/RestfulWebService.

What industry is Europe PubMed Central in?

Europe PubMed Central's product category is Scientific Literature Repository. Its primary akta.pro industry code is EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health). Its NAICS code is 51921 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
National Center for Biotechnology InformationRadiofrequency Microneedling: Technology, Devices, and Indications in the Modern Plastic Surgery PracticeA literature review published in the Aesthetic Surgery Journal examined radiofrequency microneedling, reviewing PubMed and Embase studies from 2010 onward on pathophysiology, devices, and outcomes. It recommends needle depths of 1.5 mm for forehead and neck, 1.0 mm for the malar region, 2.0 mm maximum for nasal side walls, and 0.5 mm for perioral skin. The authors found the procedure safe and well tolerated, with common side effects including pain, erythema, swelling and grid marks.National Center for Biotechnology InformationDigital Biomarker–Based Studies: Scoping Review of Systematic ReviewsA scoping review of systematic reviews on digital biomarkers, published in 2019-2020, identified 31 eligible reviews from PubMed and the Cochrane Library. Most covered circulatory (61%) and respiratory (29%) diseases, with physical activity interventions (52%) and heart rhythm conversion (13%) most common. Digital biomarkers were used as interventions in 77% of reviews, with wearables (71%) and position sensors (68%) most prevalent.Association of Health Care JournalistsPanelists explain how to begin mastering medical studiesAHCJ hosted a panel discussion on May 2 where experts Tara Haelle, Ishani Ganguli, and Regina Nuzzo provided guidance for journalists on covering medical studies. The session detailed the phases of clinical trials, warned against statistical errors like p-hacking, and advised verifying data through databases like ClinicalTrials.gov and PubMed.